Dr. Bresalier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of California (San Francisco)Fellowship, Gastroenterology, 1979 - 1982
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1978 - 1980
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1978
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- TX State Medical License 2004 - 2026
- WA State Medical License 2023 - 2026
- CA State Medical License 1981 - 2025
- GA State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer Start of enrollment: 2003 Jun 01
- Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers Start of enrollment: 2003 Aug 20
- Efficacy of the Third Eye Retroscope Auxiliary Imaging System Start of enrollment: 2008 Mar 01
Publications & Presentations
PubMed
- 5 citationsLow Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal.Aasma Shaukat, T. L. Marsh, Seth D. Crockett, Sapna Syngal, Robert S. Bresalier
Clinical Gastroenterology and Hepatology. 2021-09-20 - 138 citationsNeutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.Zhimin Tong, Ajaikumar B. Kunnumakkara, Huamin Wang, Yoichi Matsuo, Parmeswaran Diagaradjane
Cancer Research. 2008-08-01 - 200 citationsProgress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.Gary J. Kelloff, Scott M. Lippman, Andrew J. Dannenberg, Caroline C. Sigman, Homer L. Pearce
Clinical Cancer Research. 2006-06-15
Authored Content
- Chemoprevention of Barrett’s Esophagus and Esophageal AdenocarcinomaJune 2018
- Tu1148 ENDOSCOPIC MUCOSAL RESECTION AND RADIOFREQUENCY ABLATION ARE SAFE AND EFFECTIVE IN CURATIVE TREATMENT OF EARLY ESOPHAGEAL ADENOCARCINOMAMay 2018
Press Mentions
- How to Detect Colon Cancer Without a ColonoscopyApril 27th, 2023
- Some People May Be Able to Stretch Out the Time Between Colonoscopies, Study SuggestsJanuary 19th, 2023
- UH Researcher Reports Efficient Tests That May Replace Endoscopy in the FutureJuly 6th, 2021
- Join now to see all
Grant Support
- Mucin Glycoproteins In Colon Cancer MetastasisNational Cancer Institute2002–2010
- Mucin Glycoproteins In Colon Cancer MetastasisNational Cancer Institute1996–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: